7 stories from 5 sources
Supporting Articles
Summary
Databricks signed a term sheet for a strategic funding round that values the company at $188 billion and expects to close the round later this summer. The round is led by existing investor Coatue and includes additional participants.
Why it matters
A valuation this high would reset late-stage AI pricing and influence IPO timing, secondary liquidity, and competitive fundraising across enterprise AI.
Summary
Zepto is preparing for an India IPO at a valuation well below its reported $7 billion peak. Investors are pressing on cash burn and demanding clearer evidence of a credible path to profitability for fast-delivery models.
Why it matters
A discounted Zepto IPO would reprice India’s consumer startup ecosystem and tighten capital for cash-intensive delivery models.
Summary
Lakestar closed a $300 million Resilience I fund to invest in defense and dual-use technologies aimed at strengthening Europe’s resilience and technological sovereignty. The firm framed the strategy as a response to rising security demands and the cost of maintaining freedom.
Why it matters
A dedicated $300 million vehicle signals defense tech is becoming a mainstream European VC strategy, reshaping where talent, startups, and public money converge.
Summary
Lakestar founder Klaus Hommels is warning that Europe has become dangerously dependent on US technology and is responding by raising a $300mn "resilience" fund. The fund will back European dual-use and defense technology startups.
Why it matters
Defense and resilience are becoming a primary investment thesis in Europe, reshaping startup formation, funding priorities, and government buying power.
A curated list of other prominent stories from this day.
Summary
Latigo Biotherapeutics filed to go public, signaling it plans to test public-market demand alongside other biotech companies preparing IPOs as soon as this quarter.
Why it matters
This filing is a real-time indicator of whether the biotech IPO market can provide exits and reset capital formation for VC-backed drug developers.
Summary
Apax has invested in Inspectorio, a supply chain quality and compliance software platform founded in 2016. The funding is positioned to support the company’s next stage of growth.
Why it matters
Private equity backing accelerates consolidation and standard-setting in supply chain compliance, raising the bar for digital traceability across retail and manufacturing.
Summary
Sonothera claims it can use ultrasound-based delivery to get gene therapies into cells more effectively, with potential applications in muscular dystrophy and other diseases. The approach aims to expand what tissues can be targeted and reduce some limitations of current delivery methods.
Why it matters
Better delivery is the lever that can turn more gene therapy concepts into viable products and reshape where biotech capital flows.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!